Detection of Plasma Circulating Tumor DNA in Gastric Cancer
NCT05027347 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-04-28
Summary
The aim of this study is to develop a protocol for detection of circulating tumor DNA (ctDNA) in plasma of patients with early stages of gastric cancer.
Conditions
- Circulating Tumor DNA (ctDNA)
- Gastric Cancer
Interventions
- DIAGNOSTIC_TEST
-
plasma circulating tumor DNA
A liquid biopsy assay for identification of tumor derived mutations in plasma of gastric cancer
Sponsors & Collaborators
-
University Medical Center Ho Chi Minh City (UMC)
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-10
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- Vietnam
Study Locations
More Related Trials
-
Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer
NCT03076567 ·Status: COMPLETED
-
Early Detection and Post-operative Monitoring of Gastric Cancer
NCT06232395 ·Status: RECRUITING
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05991947 ·Status: RECRUITING
-
Gastric Cancer Marker Detection and Its Kit Development
NCT05010863 ·Status: RECRUITING
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric Cancer
NCT05397548 ·Status: UNKNOWN
-
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
NCT06036563 ·Status: RECRUITING
-
Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer
NCT05336058 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Cancer Patients
NCT02288754 ·Status: UNKNOWN
-
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
NCT06023121 ·Status: COMPLETED
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
ctDNA-MRD Monitoring After Resection in Gastric Cancer
NCT06893133 ·Status: RECRUITING
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
NCT05224596 ·Status: UNKNOWN
-
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
NCT05408897 ·Status: RECRUITING
-
ctDNA Screening in Advanced HER2 Positive Gastric Cancer
NCT04520295 ·Status: UNKNOWN
-
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
NCT05901376 ·Status: UNKNOWN
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer
NCT07096752 ·Status: NOT_YET_RECRUITING
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
NCT06776835 ·Status: ENROLLING_BY_INVITATION
-
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
NCT06589388 ·Status: RECRUITING
-
Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
NCT02443948 ·Status: UNKNOWN
-
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
NCT04576858 ·Status: UNKNOWN